Hemosphere, Inc.: Series A $9.3M

Posted in I - Series A, Q - 1Q10, R - MID WEST, X - Device (Dialysis), XX - MN

Hemosphere (Eden Prairie, MN) a commercial-stage medical device company focused on vascular access for dialysis patients, closed a $9.3M Series A financing, bringing the total round to $36.3M (GRAFTcath). Participants have included Kaiser Permanente Ventures, Three Arch Partners, Ascension Health Ventures, Affinity Capital Management, Cutlass Capital and Sapient Capital Management.

Mar

2010

Advanced Cardiac Therapeutics, Inc.: Series B $5M

Posted in Q - 4Q08, R - MID ATLANTIC, R - NORTH EAST, Uncategorized, X - Anticoagulant, X - Device (Dialysis), X - Device (GI), XX - MI, XX - NH

Advanced Cardiac Therapeutics (Laguna Beach, CA) a development-stage electrophysiology and radiometry medical device company focused on energy delivery via catheters for cardiac ablation, closed a $5M Series b financing. Participants include NBGI Ventures.

Apr

2008

GraftCath, Inc.: Series D $12M

Posted in I - Series D, Q - 1Q08, R - MID WEST, X - Device (Dialysis)

GraftCath (Coon Rapids, MN) a commercialization stage medical device company focused on reducing infections for dialysis patients closed a $11.8M Series D financing. Participants include Affinity Capital Management, Ascension Health Ventures, Cutlass Capital, Sapient Capital and Three Arch Partners.

to top of page...